Steroid Withdrawal and Donor-specific Anti-HLA Antibodies in Renal Transplant Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

230

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

July 31, 2019

Study Completion Date

December 31, 2019

Conditions

Other Complication of Kidney TransplantRenal Transplant Rejection

Interventions

DRUG

Prednisone withdrawal

Withdrawal of steroids

DRUG

Prednisone continuation

Continuation of steroids

Trial Locations (5)

Carlos Haya Hospital, Málaga

Canarias University Hospital, Santa Cruz de Tenerife

Dr. Peset Hospital, Valencia

Vall d Hebron Hospital, Barcelona

Bellvitge Hospital, Barcelona

All Listed Sponsors

collaborator

Sociedad Andaluza de Trasplantes de Organos y Tejidos

OTHER

lead

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

OTHER

NCT02284464 - Steroid Withdrawal and Donor-specific Anti-HLA Antibodies in Renal Transplant Patients | Biotech Hunter | Biotech Hunter